Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018 Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …
News

Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care

August 15, 2018 Research and Development HIV, Janssen, ViiV Healthcare, pharma

Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …
News

Rotavirus vaccine shown to reduce risk of death by 34% in Malawi

August 15, 2018 Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines

A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …
News

New York sues Purdue Pharma over opioid crisis

August 15, 2018 Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …
News
gilead-sciences

Gilead CMO announces departure alongside two new exec appointments

August 15, 2018 Medical Communications, Research and Development Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
News
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
News
rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018 Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
News

NICE recommends Eli Lilly’s psoriatic arthritis drug

August 9, 2018 Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis

Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
News
AstraZeneca

AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas

August 8, 2018 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma

AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
News

Stem cells could ‘reset’ immune system in Crohn’s disease patients

August 8, 2018 Research and Development Crohn’s disease, Stem cells, crohn's disease, trials

A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …
News
congo-river

MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak

August 8, 2018 Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma

MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
News
spark_v2

Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%

August 8, 2018 Research and Development Spark Therapeutics, haemophilia, pharma

Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
News

Drugs should be preferred first-choice treatment for ADHD

August 8, 2018 Research and Development ADHD, adults, amphetmines, children, prescription, ritalin

Ritalin and other amphetamines should be the preferred first-choice medications for the short-term treatment of ADHD, according to a study …
News

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026